Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Iovance Biotherapeutics Inc (IOVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Iovance Biotherapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today reported its second quarter...

IOVA : 15.00 (+2.39%)
Iovance Biotherapeutics Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 6, 2018 / Iovance Biotherapeutics Inc (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 6, 2018 at 4:30 PM Eastern Time....

IOVA : 15.00 (+2.39%)
Iovance Biotherapeutics to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Monday, August 6, 2018

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it will report...

IOVA : 15.00 (+2.39%)
A Savvy Biotech Investor Is Betting Up To $25 Million Dollars On This $8 Stock Returning 250%... Or More?

Top-notch Great Point Partners is investing up to $25 million in Orgenesis' (ORGS) manufacturing subsidiary to enable global expansion. Company is already generating growing revenue, and this specialist...

IOVA : 15.00 (+2.39%)
ORGS : 6.92 (+0.14%)
ARNA : 36.93 (+0.63%)
Iovance Biotherapeutics and Three Additional Biotech Stocks on Our Research Desk's Radar

Stock Research Monitor: JAGX, JAZZ, and LJPC

IOVA : 15.00 (+2.39%)
JAZZ : 175.37 (-0.42%)
Iovance Biotherapeutics (IOVA) Jumps: Stock Rises 5.1%

Iovance Biotherapeutics (IOVA) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

IOVA : 15.00 (+2.39%)
ILMN : 327.30 (-0.89%)
Iovance Biotherapeutics Announces First Patient Dosed in Europe for Ongoing C-144-01 Phase 2 Trials in Metastatic Melanoma

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor infiltrating lymphocyte (TIL) technology, today announced that the first patient...

IOVA : 15.00 (+2.39%)
Advaxis Appoints Molly Henderson as Chief Financial Officer

Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced the appointment...

ADXS : 1.48 (+2.07%)
IOVA : 15.00 (+2.39%)
LBIO : 6.95 (-2.80%)
Implied Volatility Surging for Iovance Biotherapeutics (IOVA) Stock Options

Investors need to pay close attention to Iovance Biotherapeutics (IOVA) stock based on the movements in the options market lately.

IOVA : 15.00 (+2.39%)
Iovance Biotherapeutics to Present at Two Investor Conferences in June

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that company management...

IOVA : 15.00 (+2.39%)
Vitality Biopharma to Present at the 8th Annual LD Micro Invitational

Vitality Biopharma, Inc. (OTCQB:VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the...

IOVA : 15.00 (+2.39%)
STVFD : 0.6400 (+4.92%)
VBIO : 1.5400 (-0.65%)
Iovance Biotherapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update

- Company to Host Conference Call at 4:30pm ET Today -

IOVA : 15.00 (+2.39%)
Iovance Biotherapeutics to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 10, 2018

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it will report...

IOVA : 15.00 (+2.39%)
Iovance Biotherapeutics to Present at Two Upcoming Investor Conferences in May

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that company management...

IOVA : 15.00 (+2.39%)
DB : 11.45 (-3.13%)
Technical Perspectives on Biotech Stocks -- Intrexon, Iovance Biotherapeutics, Jaguar Health, and Jazz Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on XON, IOVA, JAGX, and JAZZ which can be accessed for free by signing up to www.wallstequities.com/registration....

IOVA : 15.00 (+2.39%)
JAZZ : 175.37 (-0.42%)
XON : 14.10 (-6.31%)
JAGX : 1.10 (-2.65%)
Report: Developing Opportunities within Enanta Pharmaceuticals, ServisFirst Bancshares, Lion Biotechnologies, Peapack-Gladstone Financial, Analogic, and Akcea Therapeutics -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Enanta Pharmaceuticals, Inc....

SFBS : 42.26 (+0.09%)
IOVA : 15.00 (+2.39%)
ENTA : 86.94 (-7.46%)
AKCA : 35.96 (+2.95%)
PGC : 32.68 (-0.52%)
ALOG : 83.95 (unch)
LBIO : 6.95 (-2.80%)
Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today reported its fourth quarter and...

IOVA : 15.00 (+2.39%)
Iovance Biotherapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2017 Financial Results and Provide a Corporate Update on Monday, March 12, 2018

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it will report...

IOVA : 15.00 (+2.39%)
Iovance Biotherapeutics to Present at Two Upcoming Investor Conferences in March

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that company management...

IOVA : 15.00 (+2.39%)
Johnson Fistel, LLP Announces Investigations of RH, WageWorks, Inc., BRF S.A., and Iovance Biotherapeutics, Inc.; Investors Encouraged to Contact Firm

Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against RH, WageWorks, Inc., BRF S.A., and Iovance Biotherapeutics, Inc., as detailed below:

WAGE : 54.65 (-0.27%)
BRFS : 5.24 (-3.14%)
IOVA : 15.00 (+2.39%)
RH : 151.62 (+5.00%)

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
EHC +0.54 , FTNT -0.51 , CAKE +0.54 , PLT +0.33 , AEO -0.09
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures ended the Monday session with most contracts 1 to 2 cents in the red. The USDA reported a private export sale of 213,372 MT to Mexico this morning, with the sale split between 2018/19 (142,248 MT) and 19/20 (71,124 MT). This morning&r...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar